Antibody Engineering, Reimagined by AI

AI Antibody Design
Stable Cell Line Development
OEM / ODM Manufacturing
AI Antibody Engineering

Precision Expression Platform

Proprietary CHO Cell Line

CRISPR Site-Specific Integration

UCOE Stable Expression System

From sequence → stable expression → scalable production

95%+

success rate

mg → kg

scale production

Fast

turnaround

A Deterministic Expression System

Not random integration. Not unstable expression. Engineered. Controlled. Scalable.

Proprietary CHO Cell Line Platform

High yield, Industrial scalability

CRISPR Site-Specific Integration

Defined genomic locus, Reduced clonal variability

UCOE-based Stable Expression

Long-term stable expression, Silencing-resistant

Deterministic expression, not random screening

Antibody LLM Platform

A closed-loop system integrating:

AI design
Expression prediction
Wet-lab validation

From in silico to in vitro — seamlessly.

Real Results. Real Impact.

increase in expression yield

For a leading biotech client's stable cell line project

Rescued low-expression antibodies

Revived multiple projects that competitors deemed impossible

50%

Reduced development timeline

Cut typical R&D timelines by half for IVD clients

Build your next antibody with us